熱門資訊> 正文
Processa Pharmaceuticals任命首席财务官
2024-07-17 20:19
- Chemotherapeutic drugs company Processa Pharmaceuticals (NASDAQ:PCSA) said Russell Skibsted has been appointed CFO, effective immediately.
- Skibsted succeeds James Stanker, who is retiring but will stay as an advisor.
- Skibsted, most recently, served as senior vice president and CFO of the ophthalmic pharmaceuticals company Alimera Sciences.
- Source: Press Release
More on Processa Pharmaceuticals
- POET, PCSA and BRFH are among premarket gainers
- Seeking Alpha’s Quant Rating on Processa Pharmaceuticals
- Historical earnings data for Processa Pharmaceuticals
- Financial information for Processa Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。